Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitors
Authors:
- Harald M. StaussHSHarald M. Stauss
- Gang BaoGBGang Bao
- Peter GohlkePGPeter Gohlke
- Yi-Zhun ZhuYZYi-Zhun Zhu
- Thomas RedlichTRThomas Redlich
- Thomas UngerTUThomas Unger
- 1 July 1995
- journal article
- review article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 73 (7) , 827-831
Abstract
Angiotensin converting enzyme inhibitors (ACEIs) not only reduce angiotensin II synthesis but also potentiate endogenous kinins. In addition to their antihypertensive actions, accumulated evidence has demonstrated an improvement by ACEIs of cardiac function, cardiac structural and metabolic status, and myocardial blood flow in conditions such as cardiac ischemia, left ventricular hypertrophy, and myocardial infarction. The mechanisms underlying the antihypertensive and cardioprotective actions of ACEIs are under intensive investigation. A reduction of angiotensin II synthesis is undoubtedly responsible for a major part of the antihypertensive effects of ACEIs. However, in experimental renal hypertension but not in genetic hypertension, bradykinin potentiation has been shown to partially mediate the acute and chronic antihypertensive actions of these drugs. In addition, experimental observations suggest that bradykinin potentiation plays a pivotal role in the cardioprotective effects of ACEIs.Key words: angiotensin converting enzyme inhibitors, antihypertension, cardiac function, myocardial infarction, tissue blood flow, bradykinin, angiotensin II.Keywords
This publication has 21 references indexed in Scilit:
- Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.Hypertension, 1994
- A specific B2‐bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramiprilBritish Journal of Pharmacology, 1992
- Converting enzyme inhibition in kinin-deficient brown Norway rats.Hypertension, 1990
- Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.Circulation Research, 1988
- Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension.Hypertension, 1988
- Biologic generation and metabolic effects of oxidized lipoproteinsInflammation Research, 1987
- Beneficial Effects of the Converting Enzyme Inhibitor, Ramipril, in Ischemic Rat HeartsJournal of Cardiovascular Pharmacology, 1986
- Exercise-induced myocardial capillary growth in the spontaneously hypertensive ratMicrovascular Research, 1985
- Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.Circulation, 1982
- Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril.Hypertension, 1981